Results of a randomized clinical trial comparing two radiation schedules in the palliative treatment of brain metastases
- PMID: 7681997
- DOI: 10.1016/0167-8140(93)90091-l
Results of a randomized clinical trial comparing two radiation schedules in the palliative treatment of brain metastases
Abstract
In 216 patients with brain metastases two schedules of brain irradiation were compared in a randomized trial: one course of 18 Gy/3 fractions/3 days versus the same fractionation followed by a second course of radiotherapy with a one-month time interval. The second course was identical to the first one or delivered 25 Gy/10 fractions/14 days. No difference in overall survival, nor in the neurologic response or in the incidence of complications was demonstrated. Two clinical factors appeared to be prognostic of the overall survival: the presence of multiple brain metastases and the presence of extracerebral metastases.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
